Design of cationic lipid nanoparticles for ocular delivery: Development, characterization and cytotoxicity
Design of cationic lipid nanoparticles for ocular delivery: Development, characterization and cytotoxicity
复制标题
DOI:
10.1016/j.ijpharm.2013.11.025
复制
发表时间:
2014-01-30
影响因子:
5.8
通讯作者:
Souto, Eliana B.
中科院分区:
文献类型:
--
作者:
Fangueiro, Joana F.;Andreani, Tatiana;Souto, Eliana B.
In the present study we have developed lipid nanoparticle (LN) dispersions based on a multiple emulsion technique for encapsulation of hydrophilic drugs or/and proteins by a full factorial design. In order to increase ocular retention time and mucoadhesion by electrostatic attraction, a cationic lipid, namely cetyltrimethylammonium bromide (CTAB), was added in the lipid matrix of the optimal LN dispersion obtained from the factorial design. There are a limited number of studies reporting the ideal concentration of cationic agents in LN for drug delivery. This paper suggests that the choice of the concentration of a cationic agent is critical when formulating a safe and stable LN. CTAB was included in the lipid matrix of LN, testing four different concentrations (0.25%, 0.5%, 0.75%, or 1.0%wt) and how composition affects LN behavior regarding physical and chemical parameters, lipid crystallization and polymorphism, and stability of dispersion during storage. In order to develop a safe and compatible system for ocular delivery, CTAB-LN dispersions were exposed to Human retinoblastoma cell line Y-79. The toxicity testing of the CTAB-LN dispersions was a fundamental tool to find the best CTAB concentration for development of these cationic LN, which was found to be 0.5 wt% of CTAB. (C) 2013 Elsevier B.V. All rights reserved.